PINXF vs JPM: Which Stock is Better?
Side-by-side comparison of The People's Insurance Company (Group) of China Limited and Jpmorgan Chase & Co in 2026
PINXF
The People's Insurance Company (Group) of China Limited
$0.75
JPM
Jpmorgan Chase & Co
$310.29
Key Metrics Comparison
| Metric | PINXF | JPM | Winner |
|---|---|---|---|
| Market Cap | $43.78B | $835.95B | JPM |
| P/E Ratio | 5.02 | 14.83 | PINXF |
| EPS (TTM) | $0.15 | $20.90 | JPM |
| Revenue Growth | -0.0% | 0.1% | JPM |
| Gross Margin | 14.6% | 100.0% | JPM |
Analyze PINXF
Full quant analysis
Analyze JPM
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PINXF or JPM a better investment?
Comparing PINXF and JPM: The People's Insurance Company (Group) of China Limited has a market cap of $43.78B while Jpmorgan Chase & Co has $835.95B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PINXF and JPM?
PINXF (The People's Insurance Company (Group) of China Limited) and JPM (Jpmorgan Chase & Co) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PINXF or JPM?
Based on P/E ratios, PINXF trades at a lower multiple (5.0x vs 14.8x).
Which is growing faster: PINXF or JPM?
JPM has higher revenue growth at 0.1% vs -0.0% for PINXF.
Which company is more profitable: PINXF or JPM?
Jpmorgan Chase & Co (JPM) has higher gross margins at 100.0% compared to 14.6% for PINXF.
Which is the larger company: PINXF or JPM?
Jpmorgan Chase & Co (JPM) is larger with a market cap of $835.95B compared to $43.78B for PINXF.
Should I buy PINXF or JPM in 2026?
Both PINXF and JPM have investment merit. PINXF trades at $0.75 while JPM trades at $310.29. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PINXF and JPM stock?
Key differences: Market Cap ($43.78B vs $835.95B), P/E Ratio (5.0x vs 14.8x), Revenue Growth (-0.0% vs 0.1%), Gross Margin (14.6% vs 100.0%).